MHC class II genes in HCV viral clearance of hepatitis C infected hispanic patients

Human Immunology

Volumn 64, Issue 1, 2003, Pages 99-102

  Azocar, Jose ^a   Clavijo, Olga P ^b   Yunis, Edmond J ^b  

^a Northgate Medical   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

HCV; Hispanics; HLA; MHC; Puerto Rican

Indexed keywords

HLA ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ALLELE; ARTICLE; CHRONIC DISEASE; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REMISSION; SEROLOGY; UNITED STATES; VIREMIA;

ADULT; ALLELES; FEMALE; GENES, MHC CLASS II; HEPACIVIRUS; HEPATITIS C; HISPANIC AMERICANS; HLA-DR ANTIGENS; HUMANS; MALE; VIREMIA;

EID: 0037237112     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00722-X     Document Type: Article

References (24)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C infection in the United States, 1988 through 1994. N Engl J Med 341:556, 1999.
2. Frank C, Mohamed MK, Strickland GT, Arthur RR, Magder LS, Khoby EL, Abdel-Wahab Y, Aly Ohn ES, Sallam I: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus. Lancet 355:887, 2000.
3. Memon MI, Memon MA: Hepatitis C: an epidemiological review. J Viral Hepat 9:84, 2002.
4. Lauer GM, Walker BD: Hepatitis C viral infection. N Engl J Med 345:41, 2001.
5. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC: Influence of the MHC class II genotype on outcome of infection with hepatitis C. Lancet 354:2119, 1999.
6. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC: Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev 174:90, 2000.
7. Alric L, Fort T, Izopet J, Vinel JP, Charlet JP, Selves J, Puel J, Pascal JP, Duffaut M, Abbal M: Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 113:1675, 1997.
8. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT: Association between HLA class II genotype and spontaneous clearance of hepatitis C viremia. J Hepatol 29:207, 1998.
9. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Marti D, Astemborski J, Carrington M: Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 184:16, 2001.
10. Migaguchi S, Saito H, Ebinuma H, Morizante T, Ishii H: Possible association between HLA antigens and response to interferon in Japanese patients with chronic hepatitis C. Tissue Antigens 49:605, 1997.
11. Vejbaesya S, Songsivilai S, Tanwendee T, Rachaibun S, Chantangpol R, Dharakul T: HLA association with hepatitis C viral infection. Hum Immunol 61:348, 1999.
12. Yunis JJ, Delgado MB, Lee-Lewandroski E, Yunis EJ, Bing DH: Rapid identification of HLA-DRw53-positive samples by a generic DRB-PCR amplification without further analysis. Tissue Antigens 40:41, 1992.
13. Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL: HLA-cw*04 and hepatitis C virus persistence. J Virol 76:4792, 2002.
14. Cereb N, Maye P, Lee S, Kong Y, Yang SY: Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens 45:1, 1995.
15. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantion. Tissue Antigens 39:225, 1992.
16. Lechner F, Wong DK, Dumbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499, 2000.
17. Valdez H, Anthony D, Farukhi F, Patki A, Salkowitz J, Heeger P, Peterson DL, Post AB, Asaad R, Lederman MM: Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. AIDS 14:2239, 2000.
18. Beld M, Penning M, Lukashov V, McMorrow M, Roos M, Pakker N, van den Hoek A, Goudsmit J: Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 244:504, 1998.
19. Fanning LJ, Levis J, Kenny-Walsh E, Wynne F, Whelton M, Shanahan F: Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population. Hepatology 31:1334, 2000.
20. McKiernan S, Keller D: Immunogenetic of hepatitis C virus. J Viral Hepat 11:13, 2000.
21. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL: A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67:429, 1997.
22. Kikuchi I, Ueda A, Mihara K, Miyanaga O, Machidori H, Ishikawa E, Tamura K: The effect of HLA alleles on response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 10:859, 1998.
23. Zavaglia C, Martinetti M, Silini E, Botelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G: Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 28:1, 1998.
24. Wucherpfenning KE, Strominger JL: Selective binding of self peptides to disease-associated major histocompatability complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 181:1597, 1995.